VEGF as a neg regulator of erythropoiesis. Paper uses IMCL's DC101 Ab. <A HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16799557&query_hl=12&itool=pubmed_docsum" target="_blank">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&l...</A> Also Regeneron has a patent using VEGF inhibitors to treat anemia. <A HREF="http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=vegf&s2=regeneron&OS=vegf+AND+regeneron&RS=vegf+AND+regeneron" target="_blank">http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...</A>